Key facts
- Notable investors include 326 Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for THE NU
- ·The full record, as it builds
Funding rounds
No funding rounds for THE NU are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About THE NU
Developer of a holistic systems biology testing platform designed to transform the world of longevity and well-being. The company's platform offers genome, microbiome, epigenome, and blood testing solutions, and also provides a comprehensive understanding of genetic makeup, microbial composition, epigenetic factors, and crucial blood biomarkers, enabling to generation of a detailed picture of health and personalized recommendations for optimal well-being.
- Sector
- Healthcare
- HQ
- Leiden, Netherlands
- Founded
- 2020
- Employees
- 107
- Website
- thenu.com/
- Ownership
- Privately Held (backing)
THE NU doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in THE NU shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on THE NU in its N-PORT filings yet. We sweep new filings monthly.